{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:28:34Z","timestamp":1770812914960,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019540","name":"Science Fund for Distinguished Young Scholars of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H270006"],"award-info":[{"award-number":["LY21H270006"]}],"id":[{"id":"10.13039\/501100019540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gut microbiota plays a significant role in the development and treatment of gouty arthritis. Simiao decoction has been shown to alleviate gouty arthritis by inhibiting inflammation, regulating NLRP3 inflammasome, and altering gut microbiota. However, there is no evidence to prove whether gut microbiota directly mediates the therapeutic efficiency of Simiao decoction in treating gout arthritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, fecal microbiota transplantation (FMT) was used to transfer the gut microbiota of gout arthritis mice treated with Simiao decoction or allopurinol to blank gout arthritis mice, in order to investigate whether FMT had therapeutic effects on gout arthritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both Simiao decoction and allopurinol effectively reduced the levels of serum uric acid, liver XOD activity, foot thickness, serum IL-1\u03b2, and G-CSF in gout arthritis mice. However, Simiao decoction also had additional benefits, including raising the pain threshold, reducing serum TNF-\u03b1 and IL-6, alleviating gut inflammation, and repairing intestinal pathology, which were not observed with allopurinol treatment. Moreover, Simiao decoction had a greater impact on gut microbiota than allopurinol, as it was able to restore the abundance of phylum Proteobacteria and genus <jats:italic>Helicobacter<\/jats:italic>. After transplantation into gout arthritis mice, gut microbiota altered by Simiao decoction exhibited similar therapeutic effects to those of Simiao decoction, but gut microbiota altered by allopurinol showed no therapeutic effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings demonstrates that Simiao decoction can alleviate gout arthritis symptoms by regulating gut microbiota.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-023-04042-4","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T13:04:38Z","timestamp":1687352678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoying","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"4042_CR1","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s10067-020-05090-8","volume":"39","author":"M Wu","year":"2020","unstructured":"Wu M, Tian Y, Wang Q, Guo C. Gout: a disease involved with complicated immunoinflammatory responses: a narrative review. Clin Rheumatol. 2020;39:2849\u201359.","journal-title":"Clin Rheumatol"},{"key":"4042_CR2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s42399-020-00416-8","volume":"2","author":"J Huang","year":"2020","unstructured":"Huang J, Ma ZF, Tian Y, Lee YY. Epidemiology and prevalence of gout in Mainland China: an updated systematic review and meta-analysis. SN Compr Clin Med. 2020;2:1593\u2013606.","journal-title":"SN Compr Clin Med"},{"key":"4042_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4081\/reumatismo.2011.195","volume":"63","author":"W Grassi","year":"2011","unstructured":"Grassi W, De Angelis R. Clinical features of gout. Reumatismo. 2011;63:238\u201345.","journal-title":"Reumatismo"},{"key":"4042_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A. Gout. Mechanisms of inflammation in gout. Arthritis Res therapy. 2010;12:1\u20138.","journal-title":"Arthritis Res therapy"},{"key":"4042_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Z Guo","year":"2016","unstructured":"Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L. Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep. 2016;6:1\u201310.","journal-title":"Sci Rep"},{"key":"4042_CR6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fmicb.2017.00268","volume":"8","author":"T Shao","year":"2017","unstructured":"Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined signature of the fecal microbiome and metabolome in patients with gout. Front Microbiol. 2017;8:268.","journal-title":"Front Microbiol"},{"key":"4042_CR7","doi-asserted-by":"crossref","unstructured":"Lin X, Shao T, Wen X, Wang M, Wen C, He Z. Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL\/6 mice. Adv Rheumatol 2020, 60.","DOI":"10.1186\/s42358-020-00155-3"},{"key":"4042_CR8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","volume":"67","author":"AT Vieira","year":"2015","unstructured":"Vieira AT, Macia L, Galv\u00e3o I, Martins FS, Canesso MCC, Amaral FA, Garcia CC, Maslowski KM, De Leon E, Shim D. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis & Rheumatology. 2015;67:1646\u201356.","journal-title":"Arthritis & Rheumatology"},{"key":"4042_CR9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3920\/BM2015.0015","volume":"6","author":"A Vieira","year":"2015","unstructured":"Vieira A, Galvao I, Amaral F, Teixeira M, Nicoli J, Martins F. Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout. Beneficial microbes. 2015;6:799\u2013806.","journal-title":"Beneficial microbes"},{"key":"4042_CR10","unstructured":"Prasad C, Iqbal U, Westfall S, Prakash S, MANAGEMENT OF HYPERURICEMIA AND GOUT BY PREBIOTICS AND PROBIOTICS. : POTENTIALS AND LIMITATIONS. Int J Probiotics Prebiotics 2017, 12."},{"key":"4042_CR11","doi-asserted-by":"crossref","first-page":"109884","DOI":"10.1016\/j.pnpbp.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, Hao Y, Gu Y, Han C. New mechanism of neuroinflammation in Alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109884.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4042_CR12","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1080\/19490976.2020.1770042","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, He C, Li N, Ding L, Chen H, Wan J, Yang X, Xia L, He W, Xiong H. The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice. Gut Microbes. 2020;11:1774\u201389.","journal-title":"Gut Microbes"},{"key":"4042_CR13","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1080\/10408398.2021.1874287","volume":"62","author":"J Wang","year":"2022","unstructured":"Wang J, Chen Y, Zhong H, Chen F, Regenstein J, Hu X, Cai L, Feng F. The gut microbiota as a target to control hyperuricemia pathogenesis: potential mechanisms and therapeutic strategies. Crit Rev Food Sci Nutr. 2022;62:3979\u201389.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4042_CR14","doi-asserted-by":"crossref","first-page":"e00771","DOI":"10.1128\/mBio.00771-21","volume":"12","author":"K Sato","year":"2021","unstructured":"Sato K, Yamazaki K, Kato T, Nakanishi Y, Tsuzuno T, Yokoji-Takeuchi M, Yamada-Hara M, Miura N, Okuda S, Ohno H. Obesity-related gut microbiota aggravates alveolar bone destruction in experimental periodontitis through elevation of uric acid. MBio. 2021;12:e00771\u201300721.","journal-title":"MBio"},{"key":"4042_CR15","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3389\/fmicb.2018.02233","volume":"9","author":"Y Yu","year":"2018","unstructured":"Yu Y, Liu Q, Li H, Wen C, He Z. Alterations of the gut microbiome associated with the treatment of hyperuricaemia in male rats. Front Microbiol. 2018;9:2233.","journal-title":"Front Microbiol"},{"key":"4042_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-022-02742-9","volume":"24","author":"H-K Park","year":"2022","unstructured":"Park H-K, Lee SJ. Treatment of gouty arthritis is associated with restoring the gut microbiota and promoting the production of short-chain fatty acids. Arthritis Res Therapy. 2022;24:51.","journal-title":"Arthritis Res Therapy"},{"key":"4042_CR17","doi-asserted-by":"crossref","unstructured":"Liu Y-F, Huang Y, Wen C-Y-Z, Zhang J-J, Xing G-L, Tu S-H, Chen Z. The effects of modified simiao decoction in the treatment of gouty arthritis: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine 2017, 2017.","DOI":"10.1155\/2017\/6037037"},{"key":"4042_CR18","doi-asserted-by":"crossref","unstructured":"Wang H, Duan H, Chen S, Luo Y, Zhang Y, Liu Q, Zhang X. Chinese herbal medicine si-miao-san decoction for acute gouty arthritis: a protocol for systematic review and meta-analysis of randomized controlled trials. Medicine 2020, 99.","DOI":"10.37766\/inplasy2020.4.0163"},{"key":"4042_CR19","first-page":"1","volume":"2021","author":"H Liang","year":"2021","unstructured":"Liang H, Deng P, Ma Y-F, Wu Y, Ma Z-H, Zhang W, Wu J-D, Qi Y-Z, Pan X-Y, Huang F-S. Advances in experimental and clinical research of the gouty arthritis treatment with traditional chinese medicine. Evidence-based Complement Altern Med. 2021;2021:1\u201315.","journal-title":"Evidence-based Complement Altern Med"},{"key":"4042_CR20","unstructured":"Tian R. Clinical observation on treating gouty arthritis with modified Simiao decoction and external application of traditional chinese medicine. Int J Traditional Chin Med 2014:600\u20133."},{"key":"4042_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jep.2012.04.052","volume":"142","author":"J Hua","year":"2012","unstructured":"Hua J, Huang P, Zhu C-M, Yuan X, Yu C-H. Anti-hyperuricemic and nephroprotective effects of modified Simiao Decoction in hyperuricemic mice. J Ethnopharmacol. 2012;142:248\u201352.","journal-title":"J Ethnopharmacol"},{"key":"4042_CR22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12906-022-03757-0","volume":"22","author":"G Shui","year":"2022","unstructured":"Shui G, Cai Z, Wang F, Chen T, Huang X, Cai Y, Mi X. Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation. BMC Complement Med Ther. 2022;22:278.","journal-title":"BMC Complement Med Ther"},{"key":"4042_CR23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12906-022-03622-0","volume":"22","author":"H Xu","year":"2022","unstructured":"Xu H, Wu J, Wang S, Xu L, Liu P, Shi Y, Wu S, Deng L, Chen X. Network pharmacology and in vivo experiments reveal the pharmacological effects and molecular mechanisms of Simiao Powder in prevention and treatment for gout. BMC Complement Med Ther. 2022;22:152.","journal-title":"BMC Complement Med Ther"},{"key":"4042_CR24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fphar.2020.00955","volume":"11","author":"X Lin","year":"2020","unstructured":"Lin X, Shao T, Huang L, Wen X, Wang M, Wen C, He Z. Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem. Front Pharmacol. 2020;11:955.","journal-title":"Front Pharmacol"},{"key":"4042_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel J, Chung J, Yaksh T. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"4042_CR26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/j.pain.0000000000001137","volume":"159","author":"A Marcotti","year":"2018","unstructured":"Marcotti A, Miralles A, Dominguez E, Pascual E, Gomis A, Belmonte C, de la Pe\u00f1a E. Joint nociceptor nerve activity and pain in an animal model of acute gout and its modulation by intra-articular hyaluronan. Pain. 2018;159:739.","journal-title":"Pain"},{"key":"4042_CR27","doi-asserted-by":"crossref","first-page":"10665","DOI":"10.7150\/thno.43528","volume":"10","author":"J Wu","year":"2020","unstructured":"Wu J, Wei Z, Cheng P, Qian C, Xu F, Yang Y, Wang A, Chen W, Sun Z, Lu Y. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis. Theranostics. 2020;10:10665.","journal-title":"Theranostics"},{"key":"4042_CR28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1159\/000521273","volume":"40","author":"W-R Xie","year":"2022","unstructured":"Xie W-R, Yang X-Y, Deng Z-H, Zheng Y-M, Zhang R, Wu L-H, Cai J-Y, Kong L-P, Xia HH-X, He X-X. Effects of washed microbiota transplantation on serum uric acid levels, symptoms, and intestinal barrier function in patients with acute and recurrent gout: a pilot study. Dig Dis. 2022;40:684\u201390.","journal-title":"Dig Dis"},{"key":"4042_CR29","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3389\/fcimb.2022.1051682","volume":"12","author":"S Tong","year":"2022","unstructured":"Tong S, Zhang P, Cheng Q, Chen M, Chen X, Wang Z, Lu X, Wu H. The role of gut microbiota in gout: is gut microbiota a potential target for gout treatment. Front Cell Infect Microbiol. 2022;12:1786.","journal-title":"Front Cell Infect Microbiol"},{"key":"4042_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.25122\/jml-2020-0065","volume":"13","author":"VE Kondratiuk","year":"2020","unstructured":"Kondratiuk VE, Tarasenko OM, Karmazina OM, Taranchuk VV. Impact of the synbiotics and urate-lowering therapy on gut microbiota and cytokine profile in patients with chronic gouty arthritis. J Med Life. 2020;13:490.","journal-title":"J Med Life"},{"key":"4042_CR31","doi-asserted-by":"crossref","unstructured":"Schlesinger N, Brunetti L. Beyond urate lowering: analgesic and anti-inflammatory properties of allopurinol. Seminars in arthritis and rheumatism. Elsevier; 2020: 444\u201350.","DOI":"10.1016\/j.semarthrit.2019.11.009"},{"key":"4042_CR32","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1039\/D0FO03199B","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhang B, Zhao X, Lin Y, Wang J, Wang X, Hu N, Wang S. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Food Funct. 2021;12:5637\u201349.","journal-title":"Food Funct"},{"key":"4042_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrgastro.2012.14","volume":"9","author":"I Mukhopadhya","year":"2012","unstructured":"Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD\u2014what role do Proteobacteria play? Nat reviews Gastroenterol Hepatol. 2012;9:219\u201330.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"key":"4042_CR34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chom.2012.07.004","volume":"12","author":"FA Carvalho","year":"2012","unstructured":"Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, Gonz\u00e1lez A. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe. 2012;12:139\u201352.","journal-title":"Cell Host Microbe"},{"key":"4042_CR35","first-page":"1","volume":"27","author":"EO M\u00e9ndez-Salazar","year":"2021","unstructured":"M\u00e9ndez-Salazar EO, V\u00e1zquez-Mellado J, Casimiro-Soriguer CS, Dopazo J, \u00c7ubuk C, Zamudio-Cuevas Y, Francisco-Balderas A, Mart\u00ednez-Flores K, Fern\u00e1ndez-Torres J, Lozada-P\u00e9rez C. Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism. Mol Med. 2021;27:1\u201313.","journal-title":"Mol Med"},{"key":"4042_CR36","doi-asserted-by":"crossref","unstructured":"Yuan X, Chen R, Zhang Y, Lin X, Yang X. Altered gut microbiota in children with hyperuricemia. Front Endocrinol 2022, 13.","DOI":"10.3389\/fendo.2022.848715"},{"key":"4042_CR37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/1040841X.2021.1924117","volume":"47","author":"S Ochoa","year":"2021","unstructured":"Ochoa S, Collado L. Enterohepatic Helicobacter species\u2013clinical importance, host range, and zoonotic potential. Crit Rev Microbiol. 2021;47:728\u201361.","journal-title":"Crit Rev Microbiol"},{"key":"4042_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2010.00744.x","volume":"61","author":"R Hansen","year":"2011","unstructured":"Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL. Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol. 2011;61:1\u201314.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"4042_CR39","doi-asserted-by":"crossref","first-page":"e1007861","DOI":"10.1371\/journal.ppat.1007861","volume":"15","author":"J Butt","year":"2019","unstructured":"Butt J, Epplein M. Helicobacter pylori and colorectal cancer\u2014A bacterium going abroad? PLoS Pathog. 2019;15:e1007861.","journal-title":"PLoS Pathog"},{"key":"4042_CR40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/09674845.2012.11669914","volume":"69","author":"J Yakoob","year":"2012","unstructured":"Yakoob J, Abbas Z, Naz S, Islam M, Jafri W. Virulence markers of Helicobacter pylori in patients with diarrhoea-dominant irritable bowel syndrome. Br J Biomed Sci. 2012;69:6\u201310.","journal-title":"Br J Biomed Sci"},{"key":"4042_CR41","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/MIB.0000000000000318","volume":"21","author":"DB Engler","year":"2015","unstructured":"Engler DB, Leonardi I, Hartung ML, Kyburz A, Spath S, Becher B, Rogler G, M\u00fcller A. Helicobacter pylori\u2013specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18. Inflamm Bowel Dis. 2015;21:854\u201361.","journal-title":"Inflamm Bowel Dis"},{"key":"4042_CR42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41522-021-00235-2","volume":"7","author":"Y Chu","year":"2021","unstructured":"Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, Li J, Liang L, He X, Jiang Y. Metagenomic analysis revealed the potential role of gut microbiome in gout. npj Biofilms and Microbiomes. 2021;7:66.","journal-title":"npj Biofilms and Microbiomes"},{"key":"4042_CR43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker BJ, Wearsch PA, Veloo AC, Rodriguez-Palacios A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906.","journal-title":"Front Immunol"},{"key":"4042_CR44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12760","volume":"151","author":"JM Larsen","year":"2017","unstructured":"Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151:363\u201374.","journal-title":"Immunology"},{"key":"4042_CR45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.7150\/ijms.47197","volume":"18","author":"H-M Jang","year":"2021","unstructured":"Jang H-M, Park J-Y, Lee Y-J, Kang M-J, Jo S-G, Jeong Y-J, Cho N-P, Cho S-D, Kim D-J, Park J-H. TLR2 and the NLRP3 inflammasome mediate IL-1\u03b2 production in Prevotella nigrescens-infected dendritic cells. Int J Med Sci. 2021;18:432.","journal-title":"Int J Med Sci"},{"key":"4042_CR46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s40168-022-01364-2","volume":"10","author":"P Bianchimano","year":"2022","unstructured":"Bianchimano P, Britton GJ, Wallach DS, Smith EM, Cox LM, Liu S, Iwanowski K, Weiner HL, Faith JJ, Clemente JC. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis. Microbiome. 2022;10:174.","journal-title":"Microbiome"},{"key":"4042_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/microorganisms6030075","volume":"6","author":"SY Geerlings","year":"2018","unstructured":"Geerlings SY, Kostopoulos I, De Vos WM, Belzer C. Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how? Microorganisms. 2018;6:75.","journal-title":"Microorganisms"},{"key":"4042_CR48","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1039\/D2FO02702J","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu J, Jin T, Qin N, Ren X, Xia X. Live and pasteurized Akkermansia muciniphila attenuate hyperuricemia in mice through modulating uric acid metabolism, inflammation, and gut microbiota. Food Funct. 2022;13:12412\u201325.","journal-title":"Food Funct"},{"key":"4042_CR49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-014-0253-5","volume":"71","author":"S-C Xing","year":"2015","unstructured":"Xing S-C, Meng D-M, Chen Y, Jiang G, Liu X-S, Li N, Yan Y-Y, Li C-G. Study on the diversity of Bacteroides and Clostridium in patients with primary gout. Cell Biochem Biophys. 2015;71:707\u201315.","journal-title":"Cell Biochem Biophys"},{"key":"4042_CR50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14397595.2018.1442183","volume":"29","author":"H Yamanaka","year":"2019","unstructured":"Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and\/or gout: a randomised, double-blind, placebo-controlled study. Mod Rheumatol. 2019;29:146\u201350.","journal-title":"Mod Rheumatol"},{"key":"4042_CR51","doi-asserted-by":"crossref","first-page":"105767","DOI":"10.1016\/j.phrs.2021.105767","volume":"171","author":"S Dong","year":"2021","unstructured":"Dong S, Zhu M, Wang K, Zhao X, Hu L, Jing W, Lu H, Wang S. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharmacol Res. 2021;171:105767.","journal-title":"Pharmacol Res"},{"key":"4042_CR52","doi-asserted-by":"crossref","first-page":"105992","DOI":"10.1016\/j.phrs.2021.105992","volume":"175","author":"S Huang","year":"2022","unstructured":"Huang S, Hu S, Liu S, Tang B, Liu Y, Tang L, Lei Y, Zhong L, Yang S, He S. Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol Res. 2022;175:105992.","journal-title":"Pharmacol Res"}],"updated-by":[{"DOI":"10.1186\/s12906-023-04090-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000}}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04042-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04042-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04042-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:02:38Z","timestamp":1689598958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04042-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4042"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04042-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12906-023-04090-w","asserted-by":"object"}]},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12906-023-04090-w","URL":"https:\/\/doi.org\/10.1186\/s12906-023-04090-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approved protocols for the animal study were obtained from the Animal Ethics Committee of Zhejiang Chinese Medical University (protocol number: 20210816-12). All protocols in this study were carried out in accordance with relevant guidelines and regulations for using animals in compliance with the ARRIVE guidelines ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}